牛牛AI助理已提取核心訊息
Merck & Co, Inc. (MRK) reported that its Chairman, CEO & President, Davis Robert M, completed a purchase of company stock on January 22, 2024. The transaction involved the acquisition of 76,510 shares of Merck's common stock at a price of $119.43 per share. Following this transaction, Davis now directly holds a total of 348,327 shares in the company. The total value of the shares acquired is approximately $9.14 million. This transaction reflects a direct investment by the executive in the company and is indicative of his confidence in Merck's future performance.
Merck & Co, Inc. (MRK) reported that its Chairman, CEO & President, Davis Robert M, completed a purchase of company stock on January 22, 2024. The transaction involved the acquisition of 76,510 shares of Merck's common stock at a price of $119.43 per share. Following this transaction, Davis now directly holds a total of 348,327 shares in the company. The total value of the shares acquired is approximately $9.14 million. This transaction reflects a direct investment by the executive in the company and is indicative of his confidence in Merck's future performance.
默沙東公司（MRK）報告稱，其董事長、首席執行官兼總裁Davis Robert M於2024年1月22日完成了對公司股票的收購。該交易涉及以每股119.43美元的價格收購默克公司76,510股普通股。在這筆交易之後，戴維斯現在直接持有該公司總共348,327股股份。收購的股票總價值約爲914萬美元。該交易反映了該高管對公司的直接投資，表明了他對默克未來業績的信心。
默沙東公司（MRK）報告稱，其董事長、首席執行官兼總裁Davis Robert M於2024年1月22日完成了對公司股票的收購。該交易涉及以每股119.43美元的價格收購默克公司76,510股普通股。在這筆交易之後，戴維斯現在直接持有該公司總共348,327股股份。收購的股票總價值約爲914萬美元。該交易反映了該高管對公司的直接投資，表明了他對默克未來業績的信心。
有用
沒用